<!DOCTYPE html>
<html lang="tr"><head>
<script src="tumors-of-upper-gi-tract_files/libs/clipboard/clipboard.min.js"></script>
<script src="tumors-of-upper-gi-tract_files/libs/quarto-html/tabby.min.js"></script>
<script src="tumors-of-upper-gi-tract_files/libs/quarto-html/popper.min.js"></script>
<script src="tumors-of-upper-gi-tract_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="tumors-of-upper-gi-tract_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="tumors-of-upper-gi-tract_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="tumors-of-upper-gi-tract_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="tumors-of-upper-gi-tract_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.340">

  <meta name="author" content="Serdar BalcÄ±">
  <title>Title</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="tumors-of-upper-gi-tract_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="tumors-of-upper-gi-tract_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="tumors-of-upper-gi-tract_files/libs/revealjs/dist/theme/quarto.css" id="theme">
  <link href="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Title</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Serdar BalcÄ± 
</div>
</div>
</div>

</section>
<section class="slide level2">


<img data-src="img%5CTumors-of-Upper-GI-Tract0.jpg" class="r-stretch"></section>
<section id="tumors-of-upper-gi-tract" class="title-slide slide level1 center">
<h1>Tumors of Upper GI Tract</h1>

</section>

<section id="serdar-balci-md" class="title-slide slide level1 center">
<h1>Serdar BALCI, MD</h1>

</section>

<section id="tumors-of-oral-cavity" class="title-slide slide level1 center">
<h1>TUMORS OF ORAL CAVITY</h1>

</section>

<section id="squamous-cell-carcinoma" class="title-slide slide level1 center">
<h1>Squamous Cell Carcinoma</h1>
<ul>
<li><strong>Field cancerization</strong>
<ul>
<li><strong>Multiple primary tumors develop independently</strong></li>
<li><strong>Years of chronic mucosal exposure to carcinogens</strong></li>
</ul></li>
<li><strong>Two distinct pathogenic pathways</strong>
<ul>
<li><strong>Chronic alcohol and tobacco (both smoked and chewed) users</strong>
<ul>
<li><strong>TP53, p63 and NOTCH1</strong></li>
</ul></li>
<li><strong>HPV related</strong>
<ul>
<li><strong>Tonsillar crypts, base of the tongue</strong></li>
<li><strong>HPV-16</strong></li>
<li><strong>fewer mutations</strong></li>
<li><strong>overexpress p16, a cyclin-dependent kinase inhibitor</strong></li>
</ul></li>
</ul></li>
</ul>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract1.png"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract2.png"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="tumors-of-salivary-glands" class="title-slide slide level1 center">
<h1>TUMORS OF SALIVARY GLANDS</h1>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract3.png"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><strong>65% to 80% arise within the parotid</strong></p>
<p><strong>10% in the submandibular gland</strong></p>
<p><strong>remainder in the minor salivary glands, including the sublingual glands</strong></p>
<p><strong>15% to 30% of tumors in the parotid glands are malignant</strong></p>
<p><strong>40% of submandibular, 50% of minor salivary gland, and 70% to 90% of sublingual tumors are cancerous</strong></p>
<p><em>Likelihood that a salivary gland tumor is malignant is inversely proportional, roughly, to the size of the gland</em></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract4.png"></p>
<p><strong>Pleomorphic adenoma</strong></p>
<p><strong>overexpress the transcription factor PLAG1</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract5.png"></p>
<p><strong>Pleomorphic adenoma</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract6.png"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract7.png"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract8.png"></p>
<p><strong>Mucoepidermoid carcinoma</strong></p>
<p><strong>chromosome rearrangements involving MAML2</strong></p>
<p><strong>signaling protein in the Notch pathway </strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract9.png"></p>
<p><strong>Adenoid cystic carcinoma </strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract10.png"></p>
<p><strong>Adenoid cystic carcinoma </strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="odontogenic-cysts-and-tumors" class="title-slide slide level1 center">
<h1>ODONTOGENIC CYSTS AND TUMORS</h1>

</section>

<section id="odontogenic-cysts-and-tumors-1" class="title-slide slide level1 center">
<h1>Odontogenic Cysts and Tumors</h1>
<p><strong>Jaws are a common site of epithelium-lined cysts derived from odontogenic remnants</strong></p>
<p><strong>Odontogenic keratocyst is locally aggressive, with a high recurrence rate</strong></p>
<p><strong>Periapical cyst is a reactive, inflammatory lesion associated with caries or dental trauma</strong></p>
<p><strong>The most common odontogenic tumors are ameloblastoma and odontoma</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract11.png"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract12.png"></p>
</section>

<section id="esophagial-tumors" class="title-slide slide level1 center">
<h1>ESOPHAGIAL TUMORS</h1>

</section>

<section id="esophageal-adenocarcinoma" class="title-slide slide level1 center">
<h1>ESOPHAGEAL ADENOCARCINOMA</h1>

</section>

<section id="esophageal-adenocarcinoma-1" class="title-slide slide level1 center">
<h1>Esophageal adenocarcinoma</h1>
<p><strong>Arises in a background of Barrett esophagus and long-standing GERD</strong></p>
<p><strong>Risk is greater with dysplasia, further increased by tobacco use, obesity, and previous radiation therapy</strong></p>
<p><strong>Reduced adenocarcinoma risk is associated with diets rich in fresh fruits and vegetables</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract13.png"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract14.png"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract15.png"></p>
<ul>
<li><strong>Whites</strong></li>
<li><strong>7x more common in male</strong></li>
<li><strong>Highest in developed Western countries</strong>
<ul>
<li><strong>US, UK, Canada, Australia, Netherlands</strong></li>
</ul></li>
<li><strong>Lowest in Korea, Thailand, Japan, and Ecuador</strong></li>
<li><strong>The incidence has increased markedly since 1970, more rapidly than for almost any other cancer</strong>
<ul>
<li><strong>From 5% to half of all esophageal cancers in the United States</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract16.png"></p>
<p><strong>N Engl J Med 2014;371:2499-509</strong></p>
<p><strong>Progression of Barrett esophagus to adenocarcinoma</strong></p>
<p><strong>Stepwise acquisition of genetic and epigenetic changes</strong></p>
<p><strong>TP53 mutation are often present at early stages of esophageal adenocarcinoma</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract17.png"></p>
<ul>
<li><strong>Usually occurs in the distal third</strong></li>
<li><strong>May invade the adjacent gastric cardia</strong></li>
<li><strong>Early lesions</strong>
<ul>
<li><strong>flat or raised patches in otherwise intact mucosa</strong></li>
</ul></li>
<li><strong>Later</strong>
<ul>
<li><strong>large exophytic masses, infiltrate diffusely, or ulcerate and invade deeply</strong></li>
</ul></li>
</ul>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract18.png"></p>
<p><strong>Esophageal adenocarcinoma</strong></p>
<p><strong>Barrett esophagus frequently is present adjacent to the tumor</strong></p>
<p><strong>Tumors typically produce mucin and form glands</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="esophagial-squamous-cell-carcinoma" class="title-slide slide level1 center">
<h1>ESOPHAGIAL SQUAMOUS CELL CARCINOMA</h1>

</section>

<section id="squamous-cell-carcinoma-1" class="title-slide slide level1 center">
<h1>Squamous Cell Carcinoma</h1>
<p><strong>&gt;45 years of age</strong></p>
<p><strong>4x more common in males</strong></p>
<p><strong>alcohol and tobacco use, poverty, caustic esophageal injury, achalasia, Plummer-Vinson syndrome, frequent consumption of very hot beverages, and previous radiation therapy to the mediastinum</strong></p>
<p><strong>6x more common in African Americans than in whites</strong></p>
<p><strong>Highest incidences are Iran, East Anatolia, central China, Hong Kong, Argentina, Brazil, and South Africa</strong></p>
<p><strong>Use of alcohol and tobacco</strong></p>
<p><strong>Nutritional deficiencies</strong></p>
<p><strong>Polycyclic hydrocarbons, nitrosamines, fungus-contaminated foods</strong></p>
<p><strong>HPV infection in high-risk but not in low-risk regions</strong></p>
<p><strong>Half of squamous cell carcinomas occur in the middle third of the esophagus </strong></p>
<p><strong>Begins as an in situ lesion in the form of squamous dysplasia</strong></p>
<p><strong>Early lesions appear as small, gray-white plaquelike thickenings</strong></p>
<p><strong>Polypoid and protrude into and obstruct the lumen</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract19.png"></p>
<p><strong>most frequently in the midesophagus</strong></p>
<p><strong>commonly causes strictures</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract20.png"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract21.jpg"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract22.jpg"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract23.jpg"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract24.png"></p>
<p><strong>Squamous Cell Carcinoma</strong></p>
<ul>
<li><strong>Most squamous cell carcinomas are moderately to well differentiated</strong></li>
<li><strong>Other morphologic types</strong>
<ul>
<li><strong>Verrucous squamous cell carcinoma</strong></li>
<li><strong>Spindle cell carcinoma</strong></li>
<li><strong>Basaloid squamous cell carcinoma</strong></li>
</ul></li>
</ul>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract25.png"></p>
</section>

<section id="spread" class="title-slide slide level1 center">
<h1>Spread</h1>
<p><strong>rich submucosal lymphatic network</strong></p>
<p><strong>circumferential and longitudinal spread</strong></p>
<p><strong>intramural tumor nodules</strong></p>
<p><strong>Upper third favor cervical lymph nodes</strong></p>
<p><strong>Middle third favor mediastinal, paratracheal, and tracheobronchial nodes</strong></p>
<p><strong>Lower third spread to gastric and celiac nodes</strong></p>
<p><strong>N Engl J Med 2014;371:2499-509</strong></p>
</section>

<section id="neoplastic-diseases-of-the-stomach" class="title-slide slide level1 center">
<h1>NEOPLASTIC DISEASES OF THE STOMACH</h1>

</section>

<section id="gastric-polyps" class="title-slide slide level1 center">
<h1>GASTRIC POLYPS</h1>

</section>

<section id="gastric-polyps-1" class="title-slide slide level1 center">
<h1>Gastric Polyps</h1>
<p><strong>5% of upper gastrointestinal tract endoscopies</strong></p>
<p><strong>Epithelial or stromal cell hyperplasia, inflammation, ectopia, or neoplasia</strong></p>
</section>

<section id="inflammatory-and-hyperplastic-polyps" class="title-slide slide level1 center">
<h1>Inflammatory and Hyperplastic Polyps</h1>
<ul>
<li><strong>75% of all gastric polyps</strong></li>
<li><strong>50 and 60 years of age</strong></li>
<li><strong>background of chronic gastritis</strong>
<ul>
<li><strong>initiates the injury and reactive hyperplasia that cause polyp growth</strong></li>
<li><strong>If associated with H. pylori gastritis, regress after bacterial eradication</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract26.png"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract27.png"></p>
<p><strong>Multiple</strong></p>
<p><strong>Characteristically ovoid in shape</strong></p>
<p><strong>&lt;1 cm in diameter</strong></p>
<p><strong>covered by a smooth surface</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract28.png"></p>
<p><strong>Irregular, cystically dilated, and elongated foveolar glands</strong></p>
<p><strong>Lamina propria edematous with variable degrees of acute and chronic inflammation</strong></p>
<p><strong>Dysplasia increases in risk &gt;1.5 cm</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract29.png"></p>
<p><strong>Inflammatory and Hyperplastic Polyps</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract30.png"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract31.png"></p>
</section>

<section id="fundic-gland-polyps" class="title-slide slide level1 center">
<h1>Fundic Gland Polyps</h1>
<ul>
<li><strong>Sporadically</strong></li>
<li><strong>Familial adenomatous polyposis (FAP)</strong></li>
<li><strong>No neoplastic potential</strong></li>
<li><strong>Incidence has increased markedly</strong>
<ul>
<li><strong>use of proton pump inhibitors</strong></li>
</ul></li>
<li><strong>Reduced acid â increased gastrin â glandular hyperplasia</strong></li>
<li><strong>Asymptomatic or nausea, vomiting, or epigastric pain</strong></li>
<li><strong>Well-circumscribed polyps</strong></li>
<li><strong>Gastric body and fundus</strong></li>
<li><strong>Multiple, and are composed of cystically dilated, irregular glands lined by flattened parietal and chief cells</strong></li>
</ul>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract32.png"></p>
<p><strong>FLETCHER Diagnostic Histopathology of Tumors 4</strong> <strong>th</strong> __ Ed__</p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract33.png"></p>
</section>

<section id="gastric-adenoma" class="title-slide slide level1 center">
<h1>Gastric Adenoma</h1>
<p><strong>10% of all gastric polyps</strong></p>
<p><strong>50-60 years of age</strong></p>
<p><strong>Males are affected 3x more</strong></p>
<p><strong>Adenocarcinoma risk increase &gt;2cm</strong></p>
<p><strong>Carcinoma may be present in up to 30% of gastric adenomas</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>

<img data-src="img%5CTumors-of-Upper-GI-Tract34.png" class="r-stretch"><ul>
<li><strong>Most commonly in antrum</strong></li>
<li><strong>Intestinal-type columnar epithelium</strong></li>
<li><strong>By definition, all gastrointestinal adenomas exhibit epithelial dysplasia</strong>
<ul>
<li><strong>low- or high-grade</strong></li>
</ul></li>
</ul>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="gastric-adenocarcinoma" class="title-slide slide level1 center">
<h1>GASTRIC ADENOCARCINOMA</h1>

</section>

<section id="gastric-adenocarcinoma-1" class="title-slide slide level1 center">
<h1>Gastric Adenocarcinoma</h1>
<ul>
<li><strong>Most common malignancy of the stomach</strong></li>
<li><strong>&gt;90% of all gastric cancers</strong></li>
<li><strong>20x higher in Japan, Chile, Costa Rica, and Eastern Europe than in North America, northern Europe, Africa, and Southeast Asia</strong></li>
<li><strong>In Japan, 35% of newly detected cases are early gastric cancer, or tumors limited to the mucosa and submucosa</strong></li>
<li><strong>Decrease in overall gastric adenocarcinoma incidence</strong>
<ul>
<li><strong>cancer of the gastric cardia is on the rise</strong></li>
<li><strong>related to Barrett?, chronic GERD? and obesity?</strong></li>
</ul></li>
</ul>
</section>

<section id="pathogenesis-of-gastric-cancers" class="title-slide slide level1 center">
<h1>Pathogenesis of Gastric cancers</h1>
<p><strong>Genetically heterogeneous</strong></p>
<p><strong>Mutations</strong></p>
<p><strong>H.pylori</strong></p>
<p><strong>EBV</strong></p>
</section>

<section id="mutations-in-gastric-cancer" class="title-slide slide level1 center">
<h1>Mutations in Gastric Cancer</h1>
<ul>
<li><strong>Majority not hereditary</strong></li>
<li><strong>Familial gastric cancers</strong>
<ul>
<li><strong>Diffuse</strong></li>
<li><strong>intestinal</strong></li>
</ul></li>
</ul>
</section>

<section id="familial-gastric-cancer" class="title-slide slide level1 center">
<h1>Familial Gastric Cancer</h1>
<ul>
<li><strong>Diffuse type</strong></li>
<li><strong>Germline mutations in CDH1</strong>
<ul>
<li><strong>encodes E-cadherin</strong></li>
</ul></li>
<li><strong>CDH1 mutations</strong>
<ul>
<li><strong>present 50% of diffuse gastric tumors</strong></li>
</ul></li>
<li><strong>E-cadherin</strong>
<ul>
<li><strong>expression decreased in the rest</strong></li>
<li><strong>often by methylation of the CDH1 promoter</strong></li>
</ul></li>
</ul>
</section>

<section id="familial-adenomatous-polyposis" class="title-slide slide level1 center">
<h1>Familial adenomatous polyposis</h1>
<p><strong>Germline mutations in adenomatous polyposis coli ( APC) genes</strong></p>
<p><strong>Increased risk of intestinal-type gastric cancer</strong></p>
</section>

<section id="sporadic-gastric-cancer" class="title-slide slide level1 center">
<h1>Sporadic gastric cancer</h1>
<ul>
<li><strong>Sporadic intestinal-type gastric cancer</strong>
<ul>
<li><strong>acquired mutations of Î²-catenin</strong>
<ul>
<li><strong>binds to both E-cadherin and APC protein</strong></li>
</ul></li>
<li><strong>microsatellite instability</strong></li>
<li><strong>hypermethylation of genes</strong>
<ul>
<li><strong>TGFÎ²RII, BAX, IGFRII, p16/INK4a</strong></li>
</ul></li>
</ul></li>
<li><strong>Sporadic gastric cancers of both histologic types</strong>
<ul>
<li><strong>TP53 mutations</strong></li>
</ul></li>
</ul>
</section>

<section id="h.-pylori" class="title-slide slide level1 center">
<h1>H. pylori</h1>
<ul>
<li><strong>Increased production of proinflammatory proteins</strong>
<ul>
<li><strong>interleukin-1Î² (IL-1Î²)</strong></li>
<li><strong>tumor necrosis factor (TNF)</strong></li>
</ul></li>
<li><strong>Polymorphisms associated with enhanced production of cytokines</strong></li>
<li><strong>Increased risk of chronic gastritis-associated intestinal-type gastric cancer with co-existing H. pylori infection</strong></li>
</ul>
</section>

<section id="epstein-barr-virus" class="title-slide slide level1 center">
<h1>Epstein-Barr virus</h1>
<ul>
<li><strong>10% of gastric adenocarcinomas are associated with EBV</strong></li>
<li><strong>EBV episomes in these tumors frequently are clonal</strong>
<ul>
<li><strong>infection preceded neoplastic transformation</strong></li>
</ul></li>
<li><strong>TP53 mutations are uncommon in EBV-positive gastric tumors</strong>
<ul>
<li><strong>distinct molecular pathogenesis</strong></li>
</ul></li>
<li><strong>proximal stomach</strong></li>
<li><strong>diffuse morphology with a marked lymphocytic infiltrate</strong></li>
</ul>

<img data-src="img%5CTumors-of-Upper-GI-Tract35.jpg" class="r-stretch"></section>

<section id="her2-amplification" class="title-slide slide level1 center">
<h1>Her2 amplification</h1>
<ul>
<li><strong>Current important targeted therapy</strong></li>
<li><strong>ToGA trial</strong></li>
<li><strong>Immunohistochemistry</strong>
<ul>
<li><strong>cerbB2</strong></li>
</ul></li>
<li><strong>In situ hybridisation</strong>
<ul>
<li><strong>CISH</strong></li>
<li><strong>FISH</strong></li>
</ul></li>
</ul>

<img data-src="img%5CTumors-of-Upper-GI-Tract36.jpg" class="r-stretch"></section>

<section id="lauren-classification" class="title-slide slide level1 center">
<h1>Lauren classification</h1>
<p><strong>intestinal type</strong></p>
<p><strong>diffuse type</strong></p>
<p><strong>bulky</strong></p>
<p><strong>broad cohesive fronts</strong></p>
<p><strong>exophytic mass or an ulcerated tumor</strong></p>
<p><strong>glandular structures similar to esophageal and colonic adenocarcinoma</strong></p>
<p><strong>apical mucin vacuoles, and abundant mucin may be present in gland lumina</strong></p>
<ul>
<li><strong>Signet ring cells</strong>
<ul>
<li><strong>large cytoplasmic mucin vacuoles</strong></li>
<li><strong>peripherally displaced, crescent-shaped nuclei</strong></li>
</ul></li>
<li><strong>infiltrative growth</strong></li>
<li><strong>Cells infiltrate mucosa and stomach wall individually or in small clusters</strong></li>
<li><strong>desmoplastic reaction</strong></li>
<li><strong>leather bottle (Matara mide)</strong></li>
<li><strong>linitis plastica</strong></li>
</ul>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract37.png"></p>
<p><strong>Intestinal-type adenocarcinoma </strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract38.png"></p>
<p><strong>Intestinal-type adenocarcinoma </strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract39.png"></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract40.png"></p>
<p><strong>Diffuse-type adenocarcinoma </strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract41.png"></p>
<p><strong>Diffuse-type adenocarcinoma </strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract42.png"></p>
</section>

<section id="gastric-cancer" class="title-slide slide level1 center">
<h1>Gastric Cancer</h1>
<p><strong>Intestinal-type</strong></p>
<p><strong>diffuse gastric cancer</strong></p>
<ul>
<li><strong>more in high-risk areas</strong></li>
<li><strong>precursor lesions</strong>
<ul>
<li><strong>flat dysplasia and adenomas</strong></li>
</ul></li>
<li><strong>mean age at presentation 55 years</strong></li>
<li><strong>male-to-female ratio is 2â:â1</strong></li>
<li><strong>Decrease in incidence</strong>
<ul>
<li><strong>maybe due to decrease in atrophic gastritis and intestinal metaplasia</strong></li>
</ul></li>
</ul>
<p><strong>incidence is relatively uniform across countries</strong></p>
<p><strong>no identified precursor lesions</strong></p>
<p><strong>occurs at similar frequencies in males and females</strong></p>
</section>

<section id="the-cancer-genome-atlas-tcga-project-molecular-classification" class="title-slide slide level1 center">
<h1>The Cancer Genome Atlas (TCGA) projectMolecular classification</h1>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract43.png"></p>
<p><strong>Chromosomal instability</strong></p>
<p><strong>Tumours positive for EpsteinâBarr virus</strong></p>
<p><strong>genomically stable tumours</strong></p>
<p><strong>microsatellite unstable tumours</strong></p>
<p><strong>Nature 2014</strong></p>
<p><strong>doi:10.1038/nature13480</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract44.png"></p>
<p><strong>Nature 2014</strong></p>
<p><strong>doi:10.1038/nature13480</strong></p>
</section>

<section id="gastric-cancer-1" class="title-slide slide level1 center">
<h1>Gastric Cancer</h1>
<ul>
<li><strong>TNM is important as a prognostic factor</strong>
<ul>
<li><strong>The depth of invasion</strong></li>
<li><strong>Extent of nodal metastasis</strong></li>
<li><strong>Distant metastasis at the time of diagnosis</strong></li>
</ul></li>
<li><strong>Local invasion into the duodenum, pancreas, and retroperitoneum is characteristic</strong></li>
<li><strong>Surgical resection is the treatment choice</strong></li>
<li><strong>5-year survival rate for early gastric cancer can exceed 90%, even if lymph node metastases are present</strong></li>
<li><strong>5-year survival rate for advanced gastric cancer remains below 20%</strong></li>
</ul>

<img data-src="img%5CTumors-of-Upper-GI-Tract45.png" class="r-stretch"></section>

<section id="early-gastric-cancer" class="title-slide slide level1 center">
<h1>Early Gastric Cancer</h1>
<p><strong>Tumors limited to mucosa</strong></p>
<p><strong>Can be resected by endoscopic mucosal resection</strong></p>
<p><strong>Common in Japan</strong></p>
</section>

<section id="gastric-lymphoma" class="title-slide slide level1 center">
<h1>GASTRIC LYMPHOMA</h1>

</section>

<section id="gastric-lymphoma-1" class="title-slide slide level1 center">
<h1>Gastric Lymphoma</h1>
<ul>
<li><strong>5% of all gastric malignancies are primary lymphomas</strong></li>
<li><strong>MALTomas</strong>
<ul>
<li><strong>most common</strong></li>
<li><strong>indolent extranodal marginal zone B cell lymphoma</strong></li>
<li><strong>lymphomas of mucosa-associated lymphoid tissue (MALT)</strong></li>
<li><strong>H.pylori</strong></li>
</ul></li>
<li><strong>Diffuse large B cell lymphoma</strong></li>
</ul>

<img data-src="img%5CTumors-of-Upper-GI-Tract46.png" class="r-stretch"><p><strong>Gastric Lymphoma</strong></p>
<p><strong>Lymphoepithelial lesions</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="neuroendocrine-tumors" class="title-slide slide level1 center">
<h1>Neuroendocrine Tumors</h1>
<ul>
<li><strong>Carcinoid Tumor</strong></li>
<li><strong>May be associated with</strong>
<ul>
<li><strong>endocrine cell hyperplasia</strong></li>
<li><strong>Chronic atrophic gastritis</strong></li>
<li><strong>Zollinger-Ellison syndrome</strong></li>
</ul></li>
<li><strong>Grade</strong>
<ul>
<li><strong>based on mitotic activity</strong></li>
<li><strong>fraction of cells immunohistochemcially positive for Ki67, a mitotic marker</strong></li>
</ul></li>
<li><strong>Localization, extent and presence of atrophy and intestinal metaplasia are important prognostically</strong></li>
<li><strong>High-grade neuroendocrine tumors</strong>
<ul>
<li><strong>neuroendocrine carcinoma</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract47.png"></p>
<p><strong>intramural or submucosal masses</strong></p>
<p><strong>small polypoid lesions</strong></p>
<p><strong>yellow or tan in appearance</strong></p>
<p><strong>form intense desmoplastic reaction that may cause kinking of the bowel and obstruction</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract48.png"></p>
<p><strong>Neuroendocrine Tumor</strong></p>
<p><strong>islands, trabeculae, strands, glands, or sheets of uniform cells</strong></p>
<p><strong>scant, pink granular cytoplasm</strong></p>
<p><strong>round to oval stippled nucleus</strong></p>
<p><strong>salt and pepper chromatin</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="location-of-neuroendocrine-tumors" class="title-slide slide level1 center">
<h1>Location of neuroendocrine tumors</h1>
<ul>
<li><strong>Foregut</strong>
<ul>
<li><strong>stomach, duodenum proximal to the ligament of Treitz, and esophagus</strong></li>
<li><strong>rarely metastasize</strong></li>
<li><strong>cured by resection</strong></li>
<li><strong>Duodenal gastrin-producing carcinoid tumors, gastrinomas, have been associated with proton pump inhibitor therapy</strong></li>
</ul></li>
<li><strong>Midgut</strong>
<ul>
<li><strong>jejunum and ileum</strong></li>
<li><strong>often multiple</strong></li>
<li><strong>tend to be aggressive</strong></li>
<li><strong>greater depth of local invasion, increased size, and presence of necrosis and mitosis are associated with poor outcome</strong></li>
</ul></li>
<li><strong>Hindgut</strong>
<ul>
<li><strong>appendix and colorectum</strong></li>
<li><strong>discovered incidentally</strong></li>
<li><strong>appendix NETs occur at any age and are almost uniformly benign</strong></li>
<li><strong>Rectal carcinoid tumors tend to produce polypeptide hormones and may manifest with abdominal pain and weight loss; they only occasionally metastasize</strong></li>
</ul></li>
</ul>
</section>

<section id="mesenchymal-neoplasms" class="title-slide slide level1 center">
<h1>MESENCHYMAL NEOPLASMS</h1>

</section>

<section id="mesenchymal-neoplasms-1" class="title-slide slide level1 center">
<h1>Mesenchymal neoplasms</h1>
<p><strong>Leiomyoma, leiomyosarcoma</strong></p>
<p><strong>Schwannomas</strong></p>
<p><strong>Glomus tumors</strong></p>
<p><strong>Gastrointestinal Stromal Tumor</strong></p>
</section>

<section id="gastrointestinal-stromal-tumor" class="title-slide slide level1 center">
<h1>Gastrointestinal Stromal Tumor</h1>
<ul>
<li><strong>slightly more common in males</strong></li>
<li><strong>60 years of age</strong></li>
<li><strong>&lt;10% occurr in persons &lt;40 years of age</strong></li>
<li><strong>interstitial cells of Cajal </strong>
<ul>
<li><strong>express c-KIT</strong></li>
<li><strong>located in the muscularis propria</strong></li>
<li><strong>pacemaker cells for gut peristalsis</strong></li>
</ul></li>
<li><strong>c-KIT mutations</strong>
<ul>
<li><strong>75-80%</strong></li>
<li><strong>gain-of-function mutation</strong></li>
<li><strong>tyrosine kinase </strong></li>
<li><strong>receptor for stem cell factor</strong></li>
</ul></li>
<li><strong>PDGFRA</strong>
<ul>
<li><strong>8%</strong></li>
<li><strong>mutations activate a related tyrosine kinase, platelet-derived growth factor receptor A</strong></li>
</ul></li>
<li><strong>either mutation is sufficient, almost never found together</strong></li>
</ul>

<img data-src="img%5CTumors-of-Upper-GI-Tract49.png" class="r-stretch"></section>

<section id="gist" class="title-slide slide level1 center">
<h1>GIST</h1>
<ul>
<li><strong>Solitary</strong></li>
<li><strong>Well-circumscribed</strong></li>
<li><strong>Fleshy</strong></li>
<li><strong>submucosal mass</strong></li>
<li><strong>Size (5cm, 10cm cut-offs), mitotic count are important</strong></li>
<li><strong>Targeted therapy</strong>
<ul>
<li><strong>imatinib</strong></li>
</ul></li>
</ul>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract50.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract51.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract52.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CTumors-of-Upper-GI-Tract53.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="tumors-of-upper-gi-tract_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "KopyalandÄ±");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "KopyalandÄ±");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>